Anogenital herpesviral [herpes simplex] infection

AB1_ANOGENITAL_HERPES_SIMPLEX

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — A60 Hospital discharge: ICD-9 — 0541A Hospital discharge: ICD-8 — 5402 Cause of death: ICD-10 — A60 Cause of death: ICD-9 — 0541A Cause of death: ICD-8 — 5402 2 out of 7 registries used, show all original rules.	2630
4. Check minimum number of events None	2630
5. Include endpoints None	2630
6. Filter based on genotype QC (FinnGen only)	2630

Control definitions (FinnGen only)

Control exclude: AB1_SEXUAL_TRANSMISSION

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF5

NAME	AB1_ANOGENITAL_HERPES_SIMPLEX
CONTROL_EXCLUDE	AB1_SEXUAL_TRANSMISSION
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	A60
HD_ICD_9	0541A
HD_ICD_8	5402
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	A60
COD_ICD_9	0541A
COD_ICD_8	5402
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Anogenital herpesviral [herpes simplex] infection based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	17791	11901	5755
Only index persons	17294	11677	5617
Unadjusted period prevalence (%)
Whole population	0.28	0.34	0.16
Only index persons	0.36	0.43	0.21
Median age at first event (years)
Whole population	29.31	27.62	32.76
Only index persons	29.21	27.59	32.58

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2630	1996	634
Unadjusted period prevalence (%)	0.58	0.68	0.28
Median age at first event (years)	32.68	30.00	41.09

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2351: Matched controls
23511

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

J05AB11

ATC

valaciclovir; oral

14.4

323.0

1179

1539

J05AB01

ATC

aciclovir; systemic

14.1

323.0

1594

3053

A60.0

ICD-10 Finland

Herpesviral infection of genitalia and urogenital tract

541.4

323.0

1751

126

N77.1*A60.0

ICD-10 Finland

Vaginitis, vulvitis and vulvovaginitis in herpesviral [herpes simplex] infection

251.5

323.0

380

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

10.5

323.0

792

1086

A63.0

ICD-10 Finland

Anogenital (venereal) warts

24.2

210.1

305

144

N77.0*A60.0

ICD-10 Finland

Ulceration of vulva in herpesviral [herpes simplex] infection

110.1

151.2

164

A56.0

ICD-10 Finland

Chlamydial infection of lower genitourinary tract

23.9

131.2

190

D06BB03

ATC

aciclovir; topical

7.4

120.9

308

470

0541A

ICD-9 Finland

Herpes simplex, Genital herpes[HERPES GENITALIS PRIMARIUS]

+∞

89.1

N51.8*A60.0

ICD-10 Finland

Herpes simplex infection of the genitals in men

111.2

88.6

A60.9

ICD-10 Finland

Anogenital herpesviral infection, unspecified

70.5

83.0

J02AC01

ATC

fluconazole; systemic

2.3

78.5

1264

7944

N76.0

ICD-10 Finland

Acute vaginitis

3.2

56.9

338

1180

X90

ICPC

Genital herpes female

20.7

54.7

O98.3

ICD-10 Finland

Other infections with a predominantly sexual mode of transmission complicating pregnancy, childbirth and the puerperium

132.9

49.0

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

2.1

47.5

641

3499

N76.8

ICD-10 Finland

Other specified inflammation of vagina and vulva

6.7

44.7

117

181

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

43.1

744

4455

D06BB04

ATC

podophyllotoxin; topical

3.2

42.9

246

831

P01AB01

ATC

metronidazole; oral, rectal

1.8

40.9

989

6658

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.8

39.0

894

5882

N77.1

ICD-10 Finland

Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere

6.6

37.9

100

157

X23

ICPC

Fear sexually transm dis female

2.6

35.8

286

1190

R4110

NOMESCO Finland

Physiotherapy

2.0

34.6

549

3139

J01DB01

ATC

cefalexin; oral

1.9

31.5

1945

16875

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

2.2

31.2

375

1905

ULA02

NOMESCO Finland

Kolposcopy

2.2

31.1

338

1641

Z71.8

ICD-10 Finland

Other specified counselling

1.8

30.4

654

4133

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

29.9

912

6410

N05BA04

ATC

oxazepam; oral

1.8

29.8

595

3662

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

2.6

29.2

230

943

B00.9

ICD-10 Finland

Herpesviral infection, unspecified

12.3

28.8

B00.19

ICD-10 Finland

Other vesicular dermatitis caused by the herper simplex virus

12.3

28.8

A56.3

ICD-10 Finland

Chlamydial infection of anus and rectum

104.7

28.7

J01FA10

ATC

azithromycin; systemic

1.6

28.3

1481

11983

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

28.3

1288

10043

J01CA08

ATC

pivmecillinam; oral

1.6

28.2

1035

7620

A60.1

ICD-10 Finland

Herpesviral infection of perianal skin and rectum

55.7

28.2

J01MA02

ATC

ciprofloxacin; systemic

1.7

27.9

754

5088

N06AB04

ATC

citalopram; systemic

1.9

27.8

513

3066

N02AX02

ATC

tramadol; systemic, rectal

1.7

27.8

790

5407

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.9

27.6

498

2949

M79.6

ICD-10 Finland

Pain in limb

1.7

27.2

764

5203

XF400

NOMESCO Finland

ECG with 12 standard connections

2.3

26.7

275

1296

N06AX11

ATC

mirtazapine; oral

1.7

26.7

706

4721

QXA50

NOMESCO Finland

Skin cryotherapy, unspecified location

19.4

26.5

B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

4.4

26.5

229

R74

ICPC

Upper respiratory infection acute

1.6

25.9

887

6363

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.9

25.4

408

2313

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

2.0

25.3

375

2063

J05AB09

ATC

famciclovir; oral

12.8

24.9

A02BC02

ATC

pantoprazole; systemic

1.6

24.5

1280

10167

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

24.4

710

4852

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

2.0

23.2

314

1659

J01MA06

ATC

norfloxacin; oral

2.1

23.1

297

1539

N77.1*B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

3.9

22.8

259

J01AA02

ATC

doxycycline; systemic

1.6

22.5

1639

13949

M03BX02

ATC

tizanidine; oral

1.5

22.4

1421

11692

J01EA01

ATC

trimethoprim; systemic

1.7

22.1

562

3677

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

21.8

979

7418

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

4.6

21.8

173

J01MA12

ATC

levofloxacin; systemic

2.0

21.7

324

1778

N05CF02

ATC

zolpidem; oral

1.8

21.5

404

2405

Y25

ICPC

Fear sexually transm disease male

4.7

21.5

162

UJF30

NOMESCO Finland

Ileoscopy through colon

2.3

21.4

209

956

G01AA10

ATC

clindamycin; vaginal

1.8

21.1

425

2587

B37.4

ICD-10 Finland

Candidiasis of other urogenital sites

28.3

20.9

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.7

20.3

455

2859

N05AH04

ATC

quetiapine; oral

1.7

20.3

443

2764

U02

ICPC

Urinary frequency/urgency

1.9

20.1

300

1641

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.8

20.1

354

2058

SPAT1324

SPAT

Screening procedure

0.5

20.0

213

3745

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

19.8

381

2282

D06BB10

ATC

imiquimod; topical

2.8

19.4

126

461

N76.2

ICD-10 Finland

Acute vulvitis

10.1

19.4

J01FF01

ATC

clindamycin; systemic

1.6

19.0

555

3748

N05CF01

ATC

zopiclone; oral

1.6

18.8

536

3600

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

18.8

297

1661

J01FA06

ATC

roxithromycin; oral

1.5

18.6

845

6351

A51.0

ICD-10 Finland

Primary genital syphilis

191.4

18.6

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.4

18.5

167

734

N03AX16

ATC

pregabalin; oral

1.7

18.5

425

2684

R21

ICPC

Throat symptom/complaint

1.6

18.5

624

4373

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

18.3

422

2665

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

18.2

520

3487

B00.0

ICD-10 Finland

Eczema herpeticum

11.1

18.2

WX002

NOMESCO Finland

Sedation and analgesia

1.8

18.1

343

2039

N02BE01

ATC

paracetamol; systemic, rectal

1.6

17.9

1856

16583

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

17.6

1699

14895

N30.0

ICD-10 Finland

Acute cystitis

1.8

17.6

308

1783

B00.1

ICD-10 Finland

Herpesviral vesicular dermatitis

6.3

17.4

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

17.4

275

1534

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

17.4

471

3111

M01AB05

ATC

diclofenac; systemic, rectal

1.5

17.1

1407

11884

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

2.0

17.1

220

1137

R51.80

ICD-10 Finland

Headache

1.7

16.8

397

2521

A02BC05

ATC

esomeprazole; systemic

1.5

16.8

752

5604

N48.1

ICD-10 Finland

Balanoposthitis

4.8

16.7

120

M01AE02

ATC

naproxen; oral, rectal

1.4

16.6

1288

10721

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

16.6

258

1432

A54.0

ICD-10 Finland

Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess

90.7

16.6

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.6

16.4

127

514

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.6

16.4

490

3315

Y72

ICPC

Genital herpes male

40.4

16.3

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.8

16.1

313

1870

Z64.0

ICD-10 Finland

Problems related to unwanted pregnancy

2.6

16.1

122

490

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.9

16.1

236

1282

B23.1

ICD-10 Finland

HIV disease resulting in (persistent) generalized lymphadenopathy

10.1

15.9

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

15.8

794

6040

D11

ICPC

Diarrhoea

1.8

15.8

321

1947

R53

ICD-10 Finland

Malaise and fatigue

1.6

15.7

432

2855

KGD10

NOMESCO Finland

Destruction of lesion of penis

161.0

15.5

N30

ICD-10 Finland

Cystitis

2.0

15.2

198

1026

R03AC02

ATC

salbutamol; inhalant

1.4

14.9

1164

9616

K03.64

ICD-10 Finland

Dental calculus supragingival

1.5

14.8

713

5360

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

14.7

402

2649

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

14.7

204

1084

N06AX16

ATC

venlafaxine; oral

1.7

14.7

360

2304

R30.0

ICD-10 Finland

Dysuria

2.8

14.7

341

H02AB07

ATC

prednisone; oral

1.8

14.7

261

1513

N05BA01

ATC

diazepam; systemic, rectal

1.8

14.6

245

1395

R05

ICPC

Cough

1.6

14.6

476

3281

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

14.6

264

1544

N06AB10

ATC

escitalopram; oral

1.5

14.5

538

3821

J02AC02

ATC

itraconazole; systemic

1.7

14.5

364

2344

A54.6

ICD-10 Finland

Gonococcal infection of anus and rectum

150.9

14.5

Z01.2

ICD-10 Finland

Dental examination

1.4

14.5

962

7699

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

14.4

542

3859

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.6

14.3

431

2907

WW200

NOMESCO Finland

Immunization

3.0

14.3

277

R50.9

ICD-10 Finland

Fever, unspecified

1.7

14.3

290

1755

R06AE07

ATC

cetirizine; oral

1.4

14.2

1024

8307

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

14.2

683

5128

F51.0

ICD-10 Finland

Nonorganic insomnia

1.7

14.1

341

2171

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

14.1

374

2440

R05FB02

ATC

cough suppressants and expectorants

1.5

14.1

650

4837

J01DA01

ATC

[U] cefalexin; systemic

1.4

13.9

1362

11660

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

13.8

1155

9607

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

1.9

13.7

206

1127

E0000UV

ATC

1.4

13.7

859

6783

M25.5

ICD-10 Finland

Pain in joint

1.5

13.6

601

4428

S71

ICPC

Herpes simplex

6.3

13.5

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.7

13.5

294

1817

A54.5

ICD-10 Finland

Gonococcal pharyngitis

140.8

13.5

A60

ICD-10 Finland

Anogenital herpesviral [herpes simplex] infection

140.8

13.5

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.2

13.4

139

655

U01

ICPC

Dysuria/painful urination

2.0

13.4

184

975

N77.0

ICD-10 Finland

Ulceration of vulva in infectious and parasitic diseases classified elsewhere

18.3

13.4

U71

ICPC

Cystitis/urinary infection other

2.2

13.2

137

644

WX110

NOMESCO Finland

Local anesthesy

1.4

13.2

1600

14155

H02AB04

ATC

methylprednisolone; systemic

1.7

13.2

265

1598

C05AA08

ATC

fluocortolone; rectal, topical

1.8

13.1

253

1507

X92

ICPC

Chlamydia infection genital female

3.2

13.1

211

Z20.2

ICD-10 Finland

Contact with and exposure to infections with a predominantly sexual mode of transmission

2.5

13.1

106

441

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.1

13.0

145

708

TKC20

NOMESCO Finland

Catheterisation of bladder

2.5

12.9

401

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

12.9

246

1460

Z21

ICD-10 Finland

Asymptomatic human immunodeficiency virus [HIV] infection status

22.7

12.9

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

12.8

215

1222

X15

ICPC

Vaginal symptom/complaint other

2.2

12.7

131

615

N76.6

ICD-10 Finland

Ulceration of vulva

5.3

12.7

H02AB06

ATC

prednisolone; systemic

1.4

12.7

874

6989

X14

ICPC

Vaginal discharge

2.5

12.7

392

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.4

12.6

107

458

N06AX21

ATC

duloxetine; oral

1.8

12.6

240

1421

N51.8

ICD-10 Finland

Other disorders of male genital organs in diseases classified elsewhere

32.2

12.6

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

12.5

1213

10275

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

12.5

302

1917

N06AB03

ATC

fluoxetine; oral

1.7

12.5

272

1678

N01

ICPC

Headache

1.7

12.5

296

1873

A11

ICPC

Chest pain NOS

2.3

12.4

116

520

R06.0

ICD-10 Finland

Dyspnoea

1.6

12.4

392

2671

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

12.3

389

2652

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

12.2

652

4966

S29

ICPC

Skin symptom/complaint other

1.7

12.1

296

1887

LCH11

NOMESCO Finland

Pharmacologic abortion

1.9

12.0

175

947

XKD00

NOMESCO Finland

Uroflowmetry

2.0

12.0

165

875

R03BA02

ATC

budesonide; inhalant

1.6

12.0

362

2441

R05

ICD-10 Finland

Cough

1.6

11.9

347

2314

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

4.2

11.9

106

L12

ICPC

Hand/finger symptom/complaint

1.6

11.9

291

1855

C07AA05

ATC

propranolol; systemic

1.5

11.9

440

3110

R42

ICD-10 Finland

Dizziness and giddiness

1.6

11.8

343

2286

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

11.8

491

3557

LCH13

NOMESCO Finland

Vacuum aspiration from uterus after medically induced abortion

2.9

11.8

251

R2110

NOMESCO Finland

Giving the first information

1.9

11.7

183

1017

LEB00

NOMESCO Finland

Biopsy of vagina

3.7

11.7

137

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.5

11.7

540

3990

UJH02

NOMESCO Finland

Anoscopy

2.6

11.6

337

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.0

11.6

152

788

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

11.6

584

4392

LCA06

NOMESCO Finland

Biopsy of endometrium

1.7

11.6

262

1633

U13

ICPC

Bladder symptom/complaint other

2.9

11.6

237

L03

ICPC

Low back symptom/complaint

1.5

11.4

499

3647

WX110

SPAT

2.2

11.3

114

530

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.8

11.3

194

1114

L82

ICD-10 Finland

Seborrhoeic keratosis

1.8

11.2

205

1197

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.1

11.1

133

667

WX892

NOMESCO Finland

Monitored bed care

2.1

11.1

118

566

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.8

11.0

186

1061

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

11.0

458

3312

L17

ICPC

Foot/toe symptom/complaint

1.5

10.9

438

3144

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.4

10.9

808

6501

LCH00

NOMESCO Finland

Vacuum aspiration of products of conception from uterus

2.3

10.8

435

R51

ICD-10 Finland

Headache

2.0

10.8

144

754

UKC02

NOMESCO Finland

Cystoscopy

1.8

10.8

193

1121

D07CC01

ATC

betamethasone and antibiotics; topical

1.7

10.8

256

1619

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

10.7

845

6863

X58

ICD-10 Finland

Exposure to other specified factors

1.6

10.6

289

1891

L02

ICPC

Back symptom/complaint

1.7

10.6

203

1206

L05

ICPC

Flank/axilla symptom/complaint

2.3

10.5

448

M01AE01

ATC

ibuprofen; systemic, rectal

1.6

10.5

2107

19909

X57

ICD-10 Finland

Unspecified privation

3.2

10.5

167

R83

ICPC

Respiratory infection other

1.4

10.5

701

5534

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

10.5

334

2274

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

2.6

10.5

289

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

10.4

393

2783

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

10.4

317

2138

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.6

10.4

284

R4120

NOMESCO Finland

Occupational therapy

2.1

10.3

119

589

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.4

10.3

375

S18

ICPC

Laceration/cut

1.4

10.3

672

5279

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

9.9

549

4184

XCK10

NOMESCO Finland

Photography of fundus of eye

1.9

9.9

141

761

J20

ICD-10 Finland

Acute bronchitis

1.8

9.8

182

1072

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

9.7

320

2194

A02BC03

ATC

lansoprazole; oral

1.4

9.7

449

3310

M54.5

ICD-10 Finland

Low back pain

1.4

9.7

681

5405

LDB20

NOMESCO Finland

Electrocoagulation or laser therapy of cervix uteri

5.1

9.7

XQ800

NOMESCO Finland

Prick test

1.7

9.7

193

1161

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.5

9.7

297

N03AE01

ATC

clonazepam; systemic

2.1

9.6

105

511

ZXA00

NOMESCO Finland

Right side

1.5

9.6

368

2610

N06BA04

ATC

methylphenidate; oral

2.4

9.6

348

M01AH05

ATC

etoricoxib; oral

1.3

9.6

1169

10091

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.8

9.5

166

960

S06.0

ICD-10 Finland

Concussion

1.7

9.5

211

1309

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.1

9.5

158

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.4

9.5

332

ZXC10

NOMESCO Finland

Use of laser

3.2

9.4

153

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.7

9.4

179

1061

D07AB08

ATC

desonide; topical

1.7

9.4

217

1362

G02.0*B00.3

ICD-10 Finland

Herpesviral meningitis

100.4

9.4

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.7

9.4

187

1122

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.8

9.4

165

956

U07

ICPC

Urine symptom/complaint other

2.2

9.4

407

L01

ICPC

Neck symptom/complaint

1.6

9.4

283

1904

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

9.3

1076

9199

K08.80

ICD-10 Finland

Toothache NOS

1.7

9.3

194

1184

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.6

9.2

255

1679

F45.8

ICD-10 Finland

Other somatoform disorders

1.7

9.2

207

1291

N76.1

ICD-10 Finland

Subacute and chronic vaginitis

2.5

9.1

298

R35

ICD-10 Finland

Polyuria

2.2

9.1

432

G01AF05

ATC

econazole; vaginal

1.7

9.1

176

1051

AA1AD

NOMESCO Finland

CT of head and brain

1.5

9.1

297

2034

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.3

9.0

360

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.5

9.0

285

1934

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.1

9.0

100

487

R07.3

ICD-10 Finland

Other chest pain

1.8

9.0

147

831

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

9.0

124

661

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

9.0

579

4523

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

9.0

314

2184

D01

ICPC

Abdominal pain/cramps general

1.6

8.9

250

1651

G03HB01

ATC

cyproterone and estrogen; systemic

1.5

8.9

332

2341

L08

ICPC

Shoulder symptom/complaint

1.5

8.9

290

1985

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.9

8.8

134

740

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

8.7

174

1045

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

8.7

623

4945

T78.4

ICD-10 Finland

Allergy, unspecified

1.9

8.7

122

655

R01AD09

ATC

mometasone; nasal

1.3

8.7

1013

8641

TQW02

NOMESCO Finland

Removal of wart

50.2

8.7

LEB30

NOMESCO Finland

Destruction of lesion of vaginal mucosa

7.7

8.6

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

8.6

398

2928

M79.1

ICD-10 Finland

Myalgia

1.5

8.6

271

1839

D10

ICPC

Vomiting

1.7

8.5

184

1132

J01AA04

ATC

lymecycline; systemic

1.5

8.5

328

2324

G01AF04

ATC

miconazole; vaginal

2.0

8.5

108

559

H01.0

ICD-10 Finland

Blepharitis

1.9

8.5

120

646

K10.3

ICD-10 Finland

Alveolitis of jaws

1.9

8.5

124

676

Z01.7

ICD-10 Finland

Laboratory examination

1.6

8.5

209

1335

M54

ICD-10 Finland

Dorsalgia

1.6

8.4

242

1605

O04.6

ICD-10 Finland

Medical abortion, complete or unspecified, complicated by delayed or excessive haemorrhage

3.0

8.4

155

A04

ICPC

Weakness/tiredness general

1.5

8.4

258

1737

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

8.4

231

1516

P06

ICPC

Sleep disturbance

1.6

8.4

214

1378

J01MA01

ATC

ofloxacin; systemic

1.9

8.4

123

673

XLA10

NOMESCO Finland

2.0

8.4

104

532

ZXA10

NOMESCO Finland

Bilateral

1.5

8.4

280

1926

0781C

ICD-9 Finland

Other diseases due to viruses and Chlamydiae, Viral warts[CONDYLOMA ACCUMINATUM]

+∞

8.3

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.1

8.3

444

B00.5

ICD-10 Finland

Herpesviral ocular disease

10.8

8.3

F29

ICPC

Eye symptom/complaint other

1.7

8.3

156

922

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

8.2

250

1682

G44.2

ICD-10 Finland

Tension-type headache

1.5

8.2

297

2079

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

8.2

159

948

N05BA12

ATC

alprazolam; oral

1.7

8.2

187

1169

H92.0

ICD-10 Finland

Otalgia

1.9

8.2

117

630

S21

ICPC

Skin texture symptom/complaint

1.6

8.2

204

1306

R06AX27

ATC

desloratadine; oral

1.3

8.2

662

5350

N03AX09

ATC

lamotrigine; oral

1.8

8.1

132

744

KMAK

NOMESCO Finland

1.3

8.1

1257

11093

M70.6

ICD-10 Finland

Trochanteric bursitis

1.7

8.1

162

977

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.8

8.1

130

732

M54.8

ICD-10 Finland

Other dorsalgia

2.1

8.1

399

N87.0

ICD-10 Finland

Mild cervical dysplasia

2.2

8.1

365

N48.8

ICD-10 Finland

Other specified disorders of penis

6.8

8.1

RS221

NOMESCO Finland

3.8

8.0

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.8

8.0

188

LFB20

NOMESCO Finland

Destruction of lesion of vulva or perineum

6.3

8.0

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.7

8.0

147

865

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

8.0

305

2160

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.9

8.0

123

681

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.0

8.0

101

521

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.0

7.9

103

537

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

7.9

307

2179

R00.2

ICD-10 Finland

Palpitations

1.7

7.9

146

857

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

7.9

155

931

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.8

7.9

126

706

T74.1

ICD-10 Finland

Physical abuse

2.5

7.9

241

Y04

ICPC

Penis symptom/complaint other

7.8

7.9

A02BC01

ATC

omeprazole; systemic

1.4

7.8

450

3437

E000001

ATC

1.4

7.8

436

3312

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.6

7.8

193

1234

J01CA04

ATC

amoxicillin; systemic

1.3

7.8

1877

17542

N76

ICD-10 Finland

Other inflammation of vagina and vulva

3.0

7.8

141

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.1

7.8

380

Z30.0

ICD-10 Finland

General counselling and advice on contraception

1.6

7.8

214

1405

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.3

7.8

325

A29

ICPC

General symptom/complaint other

1.7

7.8

172

1069

J01AA07

ATC

tetracycline; systemic

1.4

7.8

378

2805

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.7

7.8

187

R52.2

ICD-10 Finland

Other chronic pain

2.4

7.7

275

G01AF01

ATC

metronidazole; vaginal

1.7

7.7

165

1014

M54.2

ICD-10 Finland

Cervicalgia

1.7

7.7

143

844

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.2

7.7

361

A98

ICPC

Health maint/preventive medicine

1.9

7.7

2284

22244

N30.9

ICD-10 Finland

Cystitis, unspecified

1.9

7.6

113

622

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

7.6

250

1713

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

7.6

373

2772

D07AD01

ATC

clobetasol; topical

1.5

7.5

255

1756

LDC03

NOMESCO Finland

Conisation of cervix uteri using diathermy or laser

1.8

7.5

120

676

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

7.5

317

2288

EB1AA

SPAT

1.9

7.5

100

527

TAB00

NOMESCO Finland

Lumbar puncture

1.9

7.5

513

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

7.5

485

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

7.5

232

1568

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.1

7.5

408

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.8

7.5

121

682

R01AD08

ATC

fluticasone; nasal

1.3

7.5

608

4902

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.3

7.4

289

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

7.4

833

7027

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.8

7.3

121

687

L02.8

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of other sites

3.0

7.3

131

G05.1*B00.4

ICD-10 Finland

Herpesviral meningoencephalitis

+∞

7.3

N01BB02

ATC

lidocaine; parenteral

4.2

7.3

A10AE04

ATC

insulin glargine; parenteral

1.7

7.3

135

795

N06AA09

ATC

amitriptyline; systemic

1.7

7.3

137

813

A48

ICPC

General and Unspecified, Clarification/discussion RFE/demand

1.7

7.2

140

838

F32.1

ICD-10 Finland

Moderate depressive episode

1.7

7.2

150

917

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

7.2

1292

11539

I84

ICD-10 Finland

Hemorrhoids

2.4

7.2

240

D06

ICPC

Abdominal pain localized other

1.6

7.2

169

1066

A01

ICPC

Pain general/multiple sites

1.7

7.2

131

771

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

3.6

7.2

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.7

7.2

143

865

P01

ICPC

Feeling anxious/nervous/tense

1.4

7.1

334

2456

H00.00

ICD-10 Finland

Hordeolum

2.0

7.1

475

N03AX12

ATC

gabapentin; oral

1.5

7.1

243

1680

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.9

7.1

519

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.5

7.1

D09

ICPC

Nausea

1.8

7.1

112

629

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.8

7.1

114

646

A02BC04

ATC

rabeprazole; oral

1.7

7.1

155

962

N06AX05

ATC

trazodone; oral

2.3

7.0

264

127

Kela drug reimbursment

Transplant complication

3.4

7.0

S12

ICPC

Insect bite/sting

1.9

7.0

102

557

R52.9

ICD-10 Finland

Pain, unspecified

1.7

7.0

148

909

G43.9

ICD-10 Finland

Migraine, unspecified

1.6

7.0

178

1148

R03AC03

ATC

terbutaline; inhalant

1.5

7.0

276

1968

L90.0

ICD-10 Finland

Lichen sclerosus et atrophicus

2.6

7.0

194

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.7

7.0

129

763

O99.80

ICD-10 Finland

The fear of childbirth

1.6

6.9

176

1134

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

6.9

342

2543

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

6.9

354

2649

Z72.2

ICD-10 Finland

Drug use

4.1

6.9

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

6.9

453

W79

ICPC

Unwanted pregnancy

2.2

6.9

306

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.9

6.9

526

K02.1

ICD-10 Finland

Caries of dentine

1.3

6.8

1328

11941

U29

ICPC

Urinary symptom/complaint other

2.6

6.8

172

A01AB09

ATC

miconazole; local oral

1.7

6.8

129

767

M01AH02

ATC

rofecoxib; oral

1.6

6.8

151

942

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

6.8

139

847

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

6.7

653

5385

D07AC01

ATC

betamethasone; topical

1.3

6.7

592

4816

A87.9

ICD-10 Finland

Viral meningitis, unspecified

4.3

6.7

H10

ICD-10 Finland

Conjunctivitis

1.7

6.7

145

895

N06AB05

ATC

paroxetine; oral

1.7

6.7

130

779

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.8

6.7

145

G04CA02

ATC

tamsulosin; oral

1.6

6.7

164

1049

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

3.7

6.7

EB1SA

SPAT

1.9

6.6

472

R02

ICPC

Shortness of breath/dyspnoea

1.6

6.6

188

1245

H57.1

ICD-10 Finland

Ocular pain

2.1

6.6

366

A10AA02

ATC

2.2

6.6

306

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.1

6.6

344

B02.9

ICD-10 Finland

Zoster without complication

2.1

6.6

355

A99

ICPC

Disease/condition unspecnature/site

1.7

6.6

129

777

R06AX22

ATC

ebastine; oral

1.4

6.6

366

2776

D02AE01

ATC

carbamide; topical

1.7

6.5

125

745

B00.8

ICD-10 Finland

Other forms of herpesviral infection

10.0

6.5

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.9

6.5

468

D07AC13

ATC

mometasone; topical

1.3

6.5

525

4215

TQW99

NOMESCO Finland

Other minor procedure on skin

2.2

6.5

288

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.8

6.5

100

559

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

6.5

1170

10402

LDA10

NOMESCO Finland

Curettage of cervix uteri

1.8

6.5

105

594

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

6.5

1524

13972

F32

ICD-10 Finland

Depressive episode

1.6

6.4

141

876

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

6.4

261

1869

N87.1

ICD-10 Finland

Moderate cervical dysplasia

2.1

6.4

308

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

2.6

6.4

161

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

3.3

6.4

L04AA01

ATC

[U] ciclosporin; systemic

3.3

6.4

M79.7

ICD-10 Finland

Fibromyalgia

2.0

6.4

395

L04AD01

ATC

ciclosporin; systemic

2.7

6.3

154

TQW40

NOMESCO Finland

Remowal of suture of skin

1.7

6.3

113

662

B00

ICD-10 Finland

Herpesviral [herpes simplex] infections

6.6

6.3

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.6

6.3

154

984

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

6.3

190

1276

R01AD12

ATC

fluticasone furoate; nasal

1.3

6.3

694

5815

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2.0

6.3

404

J01

ICD-10 Finland

Acute sinusitis

1.7

6.3

116

688

G50.1

ICD-10 Finland

Atypical facial pain

2.7

6.3

146

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.0

6.3

391

WX290

NOMESCO Finland

Other blockade of nerve

1.2

6.2

1101

9745

X16

ICPC

Vulval symptom/complaint

2.5

6.2

182

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.7

6.2

114

674

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.3

6.2

220

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.6

6.2

165

1076

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.6

6.2

154

988

B18.2

ICD-10 Finland

Chronic viral hepatitis C

2.8

6.2

135

J35.0

ICD-10 Finland

Chronic tonsillitis

1.6

6.2

165

1081

A03

ICPC

Fever

1.3

6.1

391

3029

R03BA01

ATC

beclometasone; inhalant

1.5

6.1

239

1699

D06BX01

ATC

metronidazole; topical

1.5

6.1

191

1297

E000006

ATC

1.7

6.1

124

754

NDS00

NOMESCO Finland

Incision and debridement of infection of tendon of wrist or hand

12.5

6.1

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.8

6.1

558

6BA02

NOMESCO Finland

8.6

6.1

R25.2

ICD-10 Finland

Cramp and spasm

2.6

6.0

162

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

207

258

8.62

156.41

1.1

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1111

5401

2.83

141.49

3.0

2.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1187

6027

2.77

138.15

3.3

2.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

706

2944

2.91

116.49

2.8

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

809

3809

2.62

103.72

3.0

1.8

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1309

7991

2.27

90.68

2.7

2.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

15.08

81.20

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

965

5449

2.22

77.94

2.1

1.7

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

15.49

77.82

2.6

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

412

1796

2.53

58.54

2.7

2.4

u/l

34.2

62.8

0.55

362

1542

(42870588) Differential panel, method unspecified - Blood

1030

6574

1.93

54.92

6.8

5.8

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

522

2689

2.17

49.79

2.8

2.6

e6/l

3.4

0.03

258

1397

(3018095) Leukocytes [#/volume] in Urine

1036

6844

1.85

47.94

3.9

3.2

e6/l

61.6

72.1

0.26

665

4534

(3006504) Eosinophils/100 leukocytes in Blood

1369

9861

1.81

47.47

7.1

5.7

2.8

0.31

1257

9233

(3022096) Basophils/100 leukocytes in Blood

1329

9489

1.81

47.45

7.2

5.8

0.7

1.34

1212

8909

(36304419) Bacteria [Presence] in Urine

813

5009

1.90

46.58

3.1

2.6

—

(3019069) Monocytes/100 leukocytes in Blood

1372

9926

1.80

46.52

7.4

6.0

8.0

0.02

1267

9380

(3028679) Herpes simplex virus Ab [Presence] in Serum

171

5.41

45.20

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

649

3754

1.97

44.62

2.1

1.6

—

(3002030) Lymphocytes/100 leukocytes in Blood

1410

10371

1.78

44.36

7.2

5.7

30.3

29.5

2.24

1296

9765

(3018010) Neutrophils/100 leukocytes in Blood

1394

10234

1.77

44.01

7.0

5.5

55.7

56.6

2.32

1285

9664

(3030467) Casts [#/volume] in Urine by Automated count

800

4979

1.87

43.94

3.2

2.7

e6/l

0.3

0.13

571

3688

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1054

7185

1.78

42.58

5.9

5.1

mmol/l

1.2

0.38

963

6561

(3037467) Urinalysis macro (dipstick) panel - Urine

1857

14906

1.84

42.47

5.1

3.8

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

527

2890

2.03

41.87

2.7

2.4

e6/l

0.8

1.2

1.15

261

1591

(3033658) Prothrombin time (PT) actual/Normal

752

4652

1.86

41.72

4.2

3.4

96.2

96.1

0.03

733

4516

(3031040) Bacteria [#/volume] in Urine by Automated count

1786

14209

1.80

41.59

5.0

3.7

e6/l

50.3

752.6

—

158

(3006315) Basophils [#/volume] in Blood

1417

10565

1.74

41.31

7.1

5.7

e9/l

0.0

0.22

1215

9325

(3001604) Monocytes [#/volume] in Blood

1413

10533

1.74

41.17

7.1

5.7

e9/l

0.5

0.15

1216

9307

(3013115) Eosinophils [#/volume] in Blood

1452

10940

1.73

40.39

7.6

6.0

e9/l

0.2

0.05

1256

9845

(3002582) Erythrocytes [#/volume] in Urine

844

5462

1.80

40.13

3.3

2.8

e6/l

34.1

92.5

1.25

612

4120

(3007164) IgA [Mass/volume] in Serum or Plasma

793

5038

1.82

40.09

1.6

1.4

g/l

2.2

0.06

448

3300

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

987

6695

1.76

39.89

1.9

1.7

pmol/l

101.5

97.9

1.47

531

3723

(3001964) Herpes simplex virus Ag [Presence] in Specimen

9.06

39.88

1.4

1.3

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1554

11988

1.72

39.14

9.7

8.4

e9/l

3.9

4.0

2.21

1328

10613

(3019198) Lymphocytes [#/volume] in Blood

1447

10954

1.71

38.99

7.1

5.7

e9/l

2.0

0.16

1268

9889

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

195

4.63

36.99

1.2

—

(40758558) Short blood count panel - Blood

780

5040

1.78

36.64

8.0

6.2

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1020

7191

1.68

34.51

4.9

4.4

g/l

37.1

36.8

0.92

935

6732

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1111

8088

1.65

32.68

6.3

5.6

mmol/l

1.2

0.45

982

6818

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1799

14787

1.69

32.55

8.1

6.5

u/l

71.1

72.6

0.77

1705

13992

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2263

19922

1.97

31.84

11.8

8.7

ml/min/173m2

93.5

93.3

0.19

1815

16252

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

182

723

2.63

30.68

1.7

1.6

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1246

9431

1.61

30.63

5.9

5.4

umol/l

10.5

10.3

0.24

1174

8881

(40768804) Tissue Pathology biopsy report

1142

8525

1.60

29.32

2.2

1.9

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

315

1636

2.05

28.31

1.9

1.8

—

(3018418) pH of Serum or Plasma

709

4757

1.67

27.68

4.3

3.4

7.4

1.84

944

(40768797) Stomach Pathology biopsy report

429

2550

1.82

25.57

1.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

807

5687

1.60

25.50

3.3

3.0

mmol/l

2.3

0.12

700

5165

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

704

4803

1.64

25.38

2.2

2.0

—

(3021960) Folate [Moles/volume] in Serum or Plasma

558

3584

1.71

25.37

1.5

1.4

nmol/l

20.9

20.6

0.26

494

3187

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

834

5945

1.59

25.01

1.4

1.3

u/ml

2.2

1.5

0.49

186

1741

(3044640) Blood type and Crossmatch panel - Blood

890

6477

1.57

24.23

2.3

2.0

—

(3009542) Hematocrit [Volume Fraction] of Blood

2379

21717

2.00

24.17

15.8

10.9

40.2

0.00

2054

17904

(21494815) CD4 cells/100 lymphocytes in Specimen

181

3.95

24.13

2.5

2.4

49.0

43.9

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

373

2178

1.83

23.44

3.0

2.4

umol/l

6.7

0.01

303

1856

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2408

22126

2.05

23.22

14.7

10.3

mg/l

20.0

19.9

0.07

1901

17062

(3021879) Hepatitis B virus core Ab [Presence] in Serum

406

2465

1.77

22.31

1.8

1.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2260

20410

1.76

22.22

5.5

4.7

mu/l

1.7

2.0

1.52

2131

19361

(3013707) Erythrocyte sedimentation rate by Westergren method

1796

15353

1.54

22.14

4.4

3.6

mm/h

9.0

9.3

0.54

1676

14424

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

436

2711

1.73

22.01

2.8

2.5

mmol/l

2.4

0.04

368

2395

(3003327) Ova and parasites identified in Stool by Light microscopy

195

929

2.19

21.82

2.0

1.7

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

159

3.97

21.63

2.4

2.8

e6/l

812.1

793.5

0.06

(3007853) Bacteria identified in Skin by Aerobe culture

387

2341

1.77

21.49

1.7

1.6

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1087

8428

1.49

21.27

2.4

2.2

nmol/l

75.4

72.9

2.14

998

7867

(3037522) Nuclear Ab [Titer] in Serum

500

3259

1.66

21.08

1.4

titre

595.7

530.8

0.27

103

627

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

119

4.44

21.07

2.7

3.1

42.3

45.8

0.46

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

103

4.73

21.04

12.3

6.6

u/ml

5613.4

211.7

0.75

(3026782) Osmolality of Urine

530

3514

1.64

20.87

2.8

2.4

mosm/kgh2o

536.4

550.2

0.66

444

2997

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

696

4936

1.56

20.59

1.9

1.7

mg/l

0.7

0.9

1.11

481

3591

(3019550) Sodium [Moles/volume] in Serum or Plasma

2304

21038

1.77

20.27

13.6

10.2

mmol/l

139.5

1.00

2247

20455

(3023368) Bacteria identified in Blood by Culture

591

4049

1.59

20.27

4.9

3.9

—

(42529406) Shigella sp [Presence] in Stool by Culture

149

656

2.35

20.12

1.3

1.1

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

405

2526

1.71

20.08

3.8

3.3

mmol/l

0.8

0.02

376

2366

(36660697) Celiac disease serology panel - Serum

341

2031

1.78

19.88

1.2

—

(3000850) Epithelial cells [#/volume] in Urine

558

3796

1.60

19.64

2.6

2.3

e6/l

11.2

7.9

0.47

481

3319

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

670

4757

1.55

19.56

2.2

2.0

u/l

135.7

215.4

1.58

634

4528

(3042936) Bacteria identified in Isolate by Culture

401

2516

1.70

19.41

2.0

1.9

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2141

19237

1.61

19.35

4.4

3.8

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2305

21115

1.74

19.19

13.9

10.3

mmol/l

3.9

3.71

2245

20477

(3048689) Calprotectin [Mass/mass] in Stool

497

3307

1.62

19.12

2.5

ug/g

91.8

106.8

0.47

389

2640

(3026008) Bacteria identified in Urine by Culture

751

5493

1.51

19.01

2.6

2.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

932

7124

1.48

18.99

3.7

3.0

u/l

29.9

30.1

0.04

883

6794

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

443

2869

1.65

18.98

3.4

3.0

ng/l

323.8

394.8

0.16

250

1621

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

883

6687

1.48

18.81

1.9

1.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

874

6614

1.48

18.65

1.8

1.7

—

(3025130) Human papilloma virus identified in Specimen

125

531

2.42

18.30

1.8

1.7

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

661

4743

1.53

18.17

3.2

3.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

144

653

2.28

18.16

1.2

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

142

649

2.26

17.58

1.2

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1996

17781

1.51

17.44

4.6

4.1

pmol/l

14.2

14.3

2.49

1845

16658

(3000494) Fungus identified in Specimen by Culture

367

2320

1.68

17.14

1.6

1.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1401

11708

1.42

17.01

3.3

2.9

ug/l

76.1

77.9

0.16

1315

11089

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

144

673

2.21

16.90

3.3

3.7

mmol/l

24.3

24.1

0.33

135

610

(3019309) Folate [Moles/volume] in Red Blood Cells

396

2578

1.63

16.45

1.6

nmol/l

1011.8

1189.5

4.01

293

2011

(3013826) Glucose [Moles/volume] in Serum or Plasma

1318

10941

1.41

16.36

5.2

4.1

mmol/l

6.3

0.28

1207

9857

(3028707) Methadone [Presence] in Urine by Screen method

154

753

2.11

16.12

5.2

3.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

302

2.77

16.08

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

302

2.77

16.08

1.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

272

1613

1.77

15.97

2.7

2.3

au/ml

17.5

23.2

0.79

136

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

232

2.98

15.34

2.5

3.9

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

305

1894

1.69

15.16

7.8

5.4

mmol/l

1.0

0.43

293

1779

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

254

1499

1.77

15.15

1.4

1.3

au/ml

22.7

37.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

487

3388

1.54

15.12

2.0

1.8

1.4

0.86

442

3072

(3024891) Influenza virus A+B Ag [Presence] in Specimen

138

665

2.13

15.01

1.1

—

(3022145) Colonoscopy Study observation

327

2077

1.66

14.90

1.4

1.3

—

(3002385) Erythrocyte distribution width [Ratio]

2127

19389

1.51

14.86

17.2

12.4

13.4

1.07

2100

19000

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

5.05

14.78

1.2

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2450

23132

1.86

14.62

10.9

8.3

u/l

25.8

25.9

0.11

2384

22475

(3013139) Helicobacter pylori Ag [Presence] in Stool

240

1409

1.77

14.56

1.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

775

5952

1.43

14.52

3.1

2.7

ng/l

19.0

35.0

2.55

335

2809

(3000570) Elastase.pancreatic [Mass/mass] in Stool

106

471

2.30

14.07

1.4

ug/g

285.0

310.3

0.52

237

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

144

724

2.05

14.01

2.4

2.0

g/l

1.1

1.2

0.46

137

682

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

140

698

2.06

13.94

2.4

2.0

g/l

0.2

1.34

132

657

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

203

1151

1.83

13.83

1.7

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

4.88

13.79

1.2

1.1

93.0

96.3

0.22

(3036481) Cortisol [Moles/volume] in Serum or Plasma

322

2078

1.63

13.73

2.0

2.1

nmol/l

372.6

376.8

0.17

295

1924

(3023511) Choriogonadotropin [Units/volume] in Urine

222

1306

1.76

13.37

1.5

1.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

646

4862

1.44

13.33

2.2

2.1

mg/l

2.6

2.7

0.52

521

4219

(3021589) Normoblasts [#/volume] in Blood

1148

9520

1.37

13.30

9.7

7.9

e9/l

0.0

0.77

904

7872

(3011288) Drugs identified in Urine by Screen method

208

1204

1.79

13.23

6.5

3.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

532

3892

1.46

12.70

1.3

u/ml

9.0

9.3

0.04

194

1674

(40768443) Skin Pathology biopsy report

145

759

1.96

12.62

1.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

211

1244

1.76

12.61

6.4

7.1

mmol/l

1.2

1.3

0.80

198

1201

(3000991) Gas panel - Venous blood

198

1146

1.79

12.60

7.9

8.7

—

(3005719) IgG [Mass/volume] in Serum or Plasma

252

1565

1.67

12.46

3.2

2.6

g/l

10.3

10.6

0.58

239

1449

(3022948) Iron [Moles/volume] in Serum or Plasma

401

2786

1.52

12.33

2.4

2.2

umol/l

14.8

14.6

0.24

374

2584

(3037121) Protein [Mass/volume] in Urine

118

582

2.08

12.12

4.2

3.1

g/l

0.2

0.3

0.54

241

(3052851) Hemolysis interference index of Serum or Plasma

106

503

2.15

12.04

3.0

2.8

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

353

2401

1.54

11.96

2.1

29.4

0.01

346

2316

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

634

4841

1.41

11.87

1.6

mmol/l

1.3

1.4

1.20

570

4228

(3016879) Cocaine [Presence] in Urine

256

1628

1.63

11.53

3.8

2.4

—

(3013512) EKG study

567

4268

1.42

11.47

3.2

2.8

—

(3009508) Creatinine [Moles/volume] in Urine

644

4961

1.39

11.38

4.5

3.3

mmol/l

8.2

8.1

0.20

559

4296

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

298

1976

1.57

11.28

3.5

3.4

33.2

31.6

1.47

207

1473

(3021601) Nitrite [Presence] in Urine by Test strip

1260

10780

1.32

11.11

5.1

4.2

estimate

0.0

0.50

198

2238

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1779

15994

1.35

11.10

3.5

2.8

u/l

35.1

37.1

0.74

1698

15299

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

180

1056

1.76

10.95

1.3

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

220

1364

1.67

10.94

4.1

2.4

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

358

2496

1.50

10.75

2.4

2.2

g/l

2.4

2.5

0.49

330

2313

(3019225) pH of Specimen

236

1499

1.63

10.68

3.6

3.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

196

1187

1.70

10.65

2.0

1.8

g/l

1.3

0.03

179

1114

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

329

2258

1.52

10.65

2.5

2.3

25.5

24.2

0.90

290

1956

(3009261) Glucose [Presence] in Urine by Test strip

1264

10875

1.31

10.47

3.5

3.1

estimate

0.0

1.06

195

2171

(3003740) Influenza virus B Ag [Presence] in Specimen

110

563

2.00

10.26

1.2

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

110

563

2.00

10.26

1.2

1.1

—

(3028300) Cannabinoids [Presence] in Urine

268

1772

1.57

10.25

3.8

2.3

—

(3027008) Opiates [Presence] in Urine

267

1767

1.57

10.17

3.8

2.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

403

2.17

10.13

2.1

1.7

g/l

2.9

3.1

0.68

324

(3024354) Oxygen [Partial pressure] in Venous blood

170

1005

1.74

10.08

2.9

2.6

kpa

4.5

4.7

0.91

163

973

(3000764) Benzodiazepines [Presence] in Urine

265

1756

1.57

10.04

3.8

2.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

248

1619

1.59

10.02

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

541

4134

1.39

9.86

1.4

1.3

iu/ml

28.5

23.2

0.46

151

1233

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

388

2.18

9.84

2.1

1.7

g/l

10.0

10.6

0.74

342

(3021447) Carbon dioxide [Partial pressure] in Venous blood

198

1228

1.66

9.84

3.6

3.5

kpa

5.8

0.03

192

1194

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

160

2.84

9.54

2.3

2.6

e6/l

525.1

497.6

0.20

130

(3027944) Amphetamines [Presence] in Urine

261

1744

1.55

9.52

3.3

2.3

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

156

2.85

9.38

2.4

2.6

e9/l

0.2

0.37

130

(3035350) Ketones [Presence] in Urine by Test strip

1243

10769

1.29

9.38

3.5

3.1

estimate

0.0

0.50

193

2175

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

424

2.09

9.30

2.0

1.7

g/l

7.0

7.3

0.88

334

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

223

1446

1.59

9.27

2.7

2.3

g/l

0.2

0.68

210

1360

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

244

1618

1.56

9.21

1.7

1.6

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1952

17977

1.33

9.18

4.7

4.2

mmol/mol

37.6

37.7

0.09

1834

17034

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

334

2.22

9.15

1.7

g/l

38.7

38.8

0.02

297

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

137

784

1.79

9.10

1.5

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

729

5900

1.33

9.04

2.9

2.4

u/l

55.9

55.6

0.08

675

5499

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

344

2464

1.46

8.96

1.9

1.7

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

424

2.06

8.93

2.1

1.7

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

424

2.06

8.93

2.1

1.7

g/l

3.6

3.8

0.58

313

(3002032) Base excess in Venous blood by calculation

192

1216

1.62

8.80

3.6

3.5

mmol/l

1.5

1.8

0.56

171

964

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

393

2.09

8.78

1.2

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

161

975

1.69

8.77

2.6

2.3

g/l

65.8

67.8

2.66

148

909

(3024928) Oxygen saturation in Venous blood

295

2.27

8.76

2.4

2.6

—

(3044889) 12 lead EKG panel

1456

12941

1.28

8.70

3.1

2.9

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

125

711

1.80

8.49

1.3

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

244

1649

1.53

8.45

1.8

1.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

154

931

1.69

8.45

1.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

203

1324

1.58

8.24

2.3

2.1

nmol/l

13.2

11.2

2.56

172

1197

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

174

2.61

8.18

2.0

mg/l

18.1

23.7

0.48

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

306

2.19

8.05

1.7

g/l

0.0

0.00

286

(3026493) Urate [Moles/volume] in Serum or Plasma

581

4618

1.33

8.04

2.6

2.2

umol/l

2255.9

3525.2

0.60

508

4134

(3027945) Reticulocytes/100 erythrocytes in Blood

221

1479

1.54

8.01

2.7

2.6

1.8

1.7

0.42

195

1318

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

188

2.53

7.99

2.0

1.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

335

2.12

7.89

1.7

g/l

0.0

0.08

314

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2115

19839

1.34

7.86

3.8

3.4

mmol/l

5.7

0.06

1963

18610

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

363

2.07

7.83

2.1

1.8

g/l

0.4

0.7

0.53

331

(3017732) Neutrophils [#/volume] in Blood

228

1546

1.52

7.78

2.0

2.4

e9/l

4.2

4.1

0.08

166

1316

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

304

2.17

7.77

1.7

g/l

0.0

0.00

285

(3011412) CD3 cells [#/volume] in Blood

209

2.42

7.76

2.4

2.6

e9/l

1.2

0.00

122

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

226

1538

1.51

7.59

1.1

1.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

409

1.99

7.57

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

108

2.99

7.50

1.2

1.1

—

(3020779) Urea [Moles/volume] in Serum or Plasma

184

1200

1.57

7.49

8.2

7.3

mmol/l

7.5

7.6

0.11

175

1151

(3032080) INR in Blood by Coagulation assay

724

5989

1.29

7.38

6.5

5.9

inr

1.1

0.14

206

2033

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

101

569

1.81

7.14

2.0

2.1

g/l

1.3

1.4

0.20

498

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1178

10360

1.25

7.11

4.1

3.9

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

165

1063

1.59

7.09

1.3

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

121

721

1.71

7.05

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

484

1.87

7.04

1.9

2.3

ug/l

236.1

340.1

0.39

438

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

141

2.65

6.97

2.1

1.8

—

(3000060) B lymphocytes [#/volume] in Blood

3.31

6.96

1.6

2.1

e6/l

200.8

131.7

0.78

(3004588) Protein electrophoresis panel - Serum or Plasma

127

772

1.68

6.88

2.1

2.0

—

(3016018) Differential panel - Cerebral spinal fluid

234

2.25

6.87

1.2

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

254

1807

1.45

6.84

2.9

2.5

ug/l

0.7

0.06

159

1007

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

399

1.93

6.70

7.6

5.2

iu/ml

858.4

778.8

0.04

(4062490)

224

2.26

6.68

1.5

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

199

2.33

6.66

1.3

1.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

231

1623

1.46

6.64

5.1

4.0

u/l

225.5

238.9

0.82

214

1546

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

711

5943

1.27

6.54

1.7

1.5

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

424

1.89

6.53

1.7

1.9

pmol/l

200.1

186.4

0.42

397

(3005322) IgE [Units/volume] in Serum or Plasma

243

1731

1.44

6.50

1.5

1.3

u/ml

202.7

199.3

0.02

222

1616

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

126

779

1.65

6.42

1.5

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

113

2.76

6.38

1.2

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

166

2.43

6.36

2.3

2.2

12.0

13.7

0.59

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

256

2.13

6.31

1.6

—

(40761511) CBC panel - Blood by Automated count

2443

23616

1.48

6.30

12.1

9.6

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

158

1037

1.56

6.29

4.3

3.5

ng/l

72.5

74.3

0.15

140

936

(3028192) IgG subclass 2 [Mass/volume] in Serum

224

2.21

6.26

1.5

1.4

g/l

2.9

0.07

153

(3024139) IgG subclass 3 [Mass/volume] in Serum

224

2.21

6.26

1.5

1.4

g/l

0.4

0.01

152

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

109

654

1.70

6.23

1.9

1.7

nmol/l

43.5

41.8

0.26

103

638

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

100

586

1.73

6.22

1.5

1.7

titre

116.0

237.9

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

225

2.20

6.20

1.5

1.4

g/l

6.4

6.5

0.04

154

(3024980) IgG subclass 4 [Mass/volume] in Serum

354

1.95

6.17

1.5

1.7

g/l

0.7

0.10

265

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

200

2.27

6.15

1.0

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

486

1.77

5.78

1.3

1.2

mmol/l

3.5

3.6

0.49

453

(3015171) Extractable nuclear Ab [Units/volume] in Serum

152

1017

1.52

5.58

1.3

u/ml

1.7

1.2

0.12

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

360

1.88

5.57

2.9

3.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

109

676

1.64

5.53

1.5

1.3

u/ml

8.4

29.1

—

(3051651) Icteric interference index of Serum or Plasma

2.75

5.53

3.7

3.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

322

1.92

5.36

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

246

1819

1.39

5.35

1.4

—

(3003338) MCHC [Mass/volume]

2131

20275

1.27

5.33

17.6

12.8

g/l

333.4

333.1

0.95

2121

20125

(1002224) Polysomnography panel

162

1110

1.49

5.32

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

100

614

1.65

5.29

1.6

1.3

u/ml

6.6

8.6

0.18

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

5.02

5.26

1.3

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

102

2.66

5.24

1.3

1.2

g/l

0.3

0.14

(3024731) MCV [Entitic volume]

2566

25171

1.80

5.21

21.1

15.2

90.6

90.0

12.84

2551

24938

(3007461) Platelets [#/volume] in Blood

2564

25146

1.78

5.21

21.1

15.3

e9/l

260.8

262.4

0.62

2526

24687

(3035941) MCH [Entitic mass]

2566

25172

1.80

5.20

21.1

15.2

30.3

30.0

11.48

2551

24937

(3021387) Prolactin [Units/volume] in Serum or Plasma

235

1735

1.39

5.16

1.5

1.6

mu/l

294.0

297.3

0.08

216

1540

(40759836) Histone Ab [Presence] in Serum by Immunoblot

183

2.20

5.16

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

183

2.20

5.16

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

183

2.20

5.16

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

183

2.20

5.16

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

183

2.20

5.16

1.2

1.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

2567

25187

1.80

5.16

21.3

15.3

g/l

134.9

135.7

2.50

2552

24948

(3026361) Erythrocytes [#/volume] in Blood

2566

25175

1.79

5.15

21.1

15.3

e12/l

4.5

8.29

2526

24692

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

466

1.74

5.14

1.6

1.3

u/ml

3.2

3.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

244

1814

1.38

5.14

1.4

—

(4010399)

177

1243

1.45

5.14

1.3

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

245

1823

1.38

5.14

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

245

1824

1.38

5.12

1.4

—

(3002256) Pathology report gross observation

328

2555

1.32

5.10

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

184

2.19

5.10

1.2

1.1

—

(3010813) Leukocytes [#/volume] in Blood

2566

25180

1.78

5.07

21.2

15.3

e9/l

6.7

6.8

0.82

2527

24683

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

321

2496

1.33

5.05

2.5

2.3

u/l

5174.9

5981.4

0.21

116

1035

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

607

1.64

5.03

1.5

1.3

u/ml

8.6

3.3

0.89

(3025941) Bacteria identified in Stool by Culture

205

1486

1.41

5.02

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

160

2.27

4.98

2.0

2.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

109

695

1.59

4.98

9.9

10.7

mmol/l

24.0

24.1

0.17

665

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

228

1688

1.38

4.94

3.5

3.4

pmol/l

4.4

4.6

2.06

202

1523

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

505

1.69

4.84

1.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.30

4.82

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

462

1.71

4.75

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

553

1.63

4.54

1.2

1.3

titre

63.6

87.4

0.70

(3051611) Lipemic interference index of Serum or Plasma

141

2.29

4.54

4.1

2.9

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

481

3991

1.25

4.54

1.6

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

135

2.31

4.52

1.7

1.4

pmol/l

36.6

58.4

0.98

(3023520) Reticulocytes [#/volume] in Blood

145

1007

1.47

4.50

2.7

2.6

e9/l

69.3

72.5

0.46

730

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.60

4.48

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.42

4.46

1.1

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

104

1564

0.65

4.45

1.8

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

258

1981

1.34

4.44

1.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

102

660

1.57

4.41

2.0

2.5

g/l

3.5

3.7

0.83

622

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

419

1.71

4.41

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

203

2.04

4.38

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

170

2.13

4.35

1.5

1.8

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

467

1.67

4.33

1.5

1.6

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

449

1.67

4.17

1.2

1.1

au/ml

6.7

13.6

—

(3009343) pH of Capillary blood

122

833

1.49

4.14

3.0

2.7

7.4

0.60

113

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

272

1.85

4.09

1.2

1.0

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

4.36

4.09

1.6

mg/l

1.6

2.3

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

4.36

4.09

1.6

mg/l

1.6

3.3

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

4.36

4.09

1.6

mg/l

0.4

6.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

454

1.65

4.01

1.1

1.0

u/ml

2.3

3.0

0.25

255

(3043238) Trisomy 21 risk [Likelihood] in Fetus

203

1528

1.36

4.00

1.4

1.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

463

1.64

3.97

3.8

2.9

mg/l

1.4

1.3

0.45

437

(3035320) C reactive protein [Mass/volume] in Body fluid

150

2.15

3.96

2.2

1.9

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.82

3.95

3.6

2.6

—

(3012516) Albumin [Mass/volume] in Urine

468

3930

1.23

3.94

4.1

3.4

mg/l

981.7

307.0

1.25

318

2576

(3049717) Cytology report of Urine Cyto stain

396

1.68

3.90

1.9

2.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

497

1.61

3.89

1.4

e6/l

26.4

21.7

0.15

380

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

497

1.61

3.89

1.5

1.4

e6/l

3009.0

8677.1

0.32

400

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.18

3.88

1.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

378

3105

1.25

3.88

2.6

2.8

ng/l

603.5

760.3

0.34

298

2522

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

234

1.90

3.88

1.7

1.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2188

21059

1.23

3.87

4.1

3.7

mmol/l

2.8

2.9

1.62

2043

19924

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

110

747

1.49

3.86

2.5

2.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

122

846

1.46

3.86

3.0

2.7

kpa

5.1

0.04

114

793

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.78

3.85

2.9

3.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

546

1.58

3.84

1.4

1.2

u/ml

39.2

32.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

235

1.89

3.83

1.8

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1344

0.66

3.76

1.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

244

1.86

3.75

1.5

—

(3000492) Spirometry study

288

2300

1.28

3.74

1.4

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

238

1.86

3.70

1.8

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

231

1.88

3.69

1.7

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

231

1.88

3.69

1.7

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

232

1.87

3.65

1.7

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.38

3.65

1.4

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

263

2084

1.29

3.63

1.4

1.3

iu/l

22.2

0.00

214

1781

(4146454)

110

2.28

3.61

2.6

2.7

—

(4035726)

184

1388

1.35

3.60

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

281

2250

1.28

3.58

1.3

1.2

iu/ml

171.9

156.1

0.22

887

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

564

1.54

3.57

2.2

mg/l

11.9

10.1

2.49

532

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

115

803

1.45

3.53

3.1

2.7

mmol/l

0.4

1.4

1.97

562

(3005033) Fetal Nuchal fold Thickness US

194

1482

1.33

3.50

1.4

—

(3028433) Virus identified in Specimen by Culture

2.71

3.49

1.4

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.43

3.47

1.6

2.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

186

1416

1.34

3.44

1.3

miu/ml

210.5

240.6

0.49

729

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.77

3.42

1.2

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

252

1.80

3.42

1.6

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

252

1.80

3.42

1.0

1.1

g/l

1.6

1.5

0.69

233

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.25

3.34

1.1

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

193

1486

1.32

3.31

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

569

1.51

3.24

1.3

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

2.39

3.22

1.5

1.3

u/ml

10.0

17.7

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

3.17

3.21

1.0

1.1

nmol/l

0.2

0.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

478

4104

1.20

3.19

5.1

4.1

mg/mmol

12.5

10.3

0.39

328

2711

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

157

1.99

3.19

1.1

1.0

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

122

879

1.41

3.19

2.3

2.2

u/l

41.7

38.8

0.86

108

816

(3006922) Hepatitis E virus Ab [Presence] in Serum

164

1.96

3.19

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

107

753

1.44

3.19

1.8

1.6

iu/ml

0.0

0.3

1.46

136

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

580

1.50

3.18

1.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

342

1.65

3.16

2.1

g/l

128.1

132.7

0.85

257

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

541

1.51

3.14

1.4

1.2

u/ml

265.4

233.3

0.50

350

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.48

3.12

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

124

900

1.40

3.12

2.4

2.8

ng/l

104.0

121.5

0.45

109

784

(4198724)

173

1.92

3.09

2.8

4.6

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.09

1.3

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2162

20891

1.20

3.08

3.8

3.4

mmol/l

4.7

4.8

1.02

2034

19900

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.39

3.06

1.2

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.46

3.04

1.0

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

153

1.97

3.04

1.1

1.2

u/l

47.4

63.4

0.83

108

(3023410) Appearance of Cerebral spinal fluid

233

1.77

3.00

1.4

1.6

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

113

814

1.41

2.98

1.1

u/ml

3.2

4.1

0.19

138

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

155

1.95

2.94

1.1

1.0

—

(3038026) Centromere Ab [Units/volume] in Serum

156

1.93

2.89

1.6

1.2

—

61.3

—

(3037756) Immunofixation for Serum or Plasma

192

1.83

2.88

2.2

1.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

122

2.06

2.87

5.0

4.2

—

(3013762) Body weight Measured

6.68

2.87

1.0

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

109

2.12

2.84

1.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

192

1513

1.29

2.82

16.9

14.7

inr

1.1

1.2

0.46

245

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.35

2.81

1.4

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

137

1.98

2.80

1.1

1.3

u/l

5.6

5.9

0.13

114

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

110

2.10

2.78

1.7

3.4

umol/l

134.6

148.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

411

1.55

2.75

1.7

1.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

411

1.55

2.75

1.3

u/ml

3.7

4.4

0.24

176

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

248

1.70

2.72

2.4

2.8

u/ml

3.7

5.0

0.64

209

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

182

1.82

2.69

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.76

2.67

1.0

1.7

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.76

2.67

1.3

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

183

1.81

2.65

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

220

1.74

2.65

1.3

1.4

pmol/l

414.3

336.7

0.55

172

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

258

1.68

2.64

1.4

1.1

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

606

1.43

2.60

2.5

2.4

0.6

0.7

2.96

586

(3024869) Neuronal Ab [Presence] in Serum

4.68

2.59

1.1

1.0

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

491

1.48

2.58

1.6

1.3

u/ml

108.8

102.7

0.16

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

223

1.71

2.54

1.2

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

316

1.59

2.53

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

412

1.52

2.52

1.4

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

527

1.46

2.51

1.5

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

248

1.66

2.46

1.7

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

538

1.44

2.46

1.6

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2145

20813

1.17

2.43

3.8

3.4

mmol/l

1.5

0.81

2006

19763

(1761868) Lipid panel - Serum or Plasma

823

8966

0.88

2.39

2.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

369

1.53

2.38

1.2

—

(3022313) Gas panel - Capillary blood

585

1.41

2.35

3.1

2.9

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

356

3061

1.19

2.35

4.1

3.8

ug/l

1.8

0.09

320

2803

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

161

1.81

2.35

1.1

iu/ml

3.5

5.8

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

260

1.63

2.33

1.3

1.2

mg/l

26.7

35.9

2.65

210

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

2.05

2.31

1.8

1.5

u/l

5.2

4.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.38

2.29

1.2

1.1

—

(3036489) Thrombin time

107

802

1.35

2.29

1.8

2.1

20.3

21.0

1.22

676

(3044927) Protein electrophoresis panel - Urine

2.03

2.26

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

423

1.48

2.26

1.4

1.2

u/ml

4.3

3.7

0.10

148

(3045414) Leukocytes [Presence] in Urine

121

926

1.32

2.25

1.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

186

1.73

2.24

2.1

1.7

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

241

1.63

2.19

1.2

1.1

—

(3022689) Creatine [Moles/volume] in Urine

2.63

2.18

1.2

1.7

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.63

2.18

1.6

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

101

757

1.35

2.18

2.8

2.2

umol/l

4.5

5.1

0.24

565

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

129

1002

1.30

2.17

1.8

2.1

ug/l

4.7

6.6

1.09

895

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

231

1923

1.22

2.16

4.3

5.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.69

2.15

1.3

1.5

ng/l

66.7

127.7

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.17

2.14

2.6

2.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.30

2.14

2.6

2.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

189

1.70

2.13

2.0

1.6

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.37

2.12

1.2

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.37

2.12

1.2

1.1

—

(21494755) Public health laboratory ask at order entry panel

309

3582

0.84

2.10

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

150

1198

1.27

2.05

1.6

1.7

mg/l

2.5

4.5

2.48

115

804

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.18

2.04

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

223

1.62

2.02

1.1

—

(3042517) Benzodiazepines panel - Urine

2.41

2.02

4.8

2.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.41

2.02

1.2

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

284

2429

1.19

2.01

3.6

3.5

21.0

0.00

925

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.08

2.01

9.4

6.5

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.08

2.01

1.4

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

163

1319

1.25

2.00

1.4

1.5

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

101

768

1.33

2.00

3.3

2.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

352

1.49

2.00

3.8

3.4

u/ml

0.4

0.17

187

(3020961) Endomysium IgA Ab [Titer] in Serum

166

1347

1.25

1.99

1.2

1.1

titre

79.0

97.9

—

(40767503) Oxygen content in Capillary blood by calculation

304

1.52

1.98

2.3

1.9

16.5

17.0

0.49

142

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.34

1.96

1.1

1.0

—

(44813793)

194

1.66

1.96

1.1

1.0

—

(3014051) Protein [Presence] in Urine by Test strip

454

1.42

1.94

1.8

—

(4094501)

404

1.45

1.94

1.2

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

4.55

1.94

1.2

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

4.55

1.94

1.2

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

3.76

1.93

1.2

1.1

—

(4268621)

274

1.54

1.92

2.6

2.3

—

(3045788) Cell count panel - Pleural fluid

2.12

1.92

1.3

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.06

1.90

2.7

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.06

1.90

2.7

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.06

1.90

2.7

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.06

1.90

2.7

1.9

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

150

1.74

1.90

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

388

3422

1.16

1.89

2.1

2.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

481

0.62

1.88

1.4

1.5

mmol/l

7.6

6.9

0.62

334

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

611

1.35

1.87

1.5

1.4

u/l

18.4

20.6

0.28

528

(3008536) Aspergillus sp Ab [Presence] in Serum

2.86

1.86

5.6

2.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

2.03

1.85

1.3

1.5

e6/l

9822.5

36607.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

138

1708

0.80

1.85

1.5

1.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.51

1.83

3.2

4.9

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

443

1.41

1.83

1.3

1.2

—

(3008898) HLA-B27 [Presence]

148

1200

1.25

1.81

1.1

—

(3012501) Base excess in Blood by calculation

352

1.46

1.81

3.5

2.9

mmol/l

1.9

2.1

0.32

208

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.76

1.79

6.4

8.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

354

1.45

1.76

1.8

1.7

e6/l

9307.3

10971.4

0.15

258

(3003888) Timothy IgE Ab [Units/volume] in Serum

653

1.33

1.76

1.1

u/ml

3.3

6.5

2.98

357

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.03

1.75

1.3

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

289

1.50

1.74

3.6

3.3

mg/l

39.3

41.0

0.04

231

(3008401) Mugwort IgE Ab [Units/volume] in Serum

619

1.34

1.74

1.1

u/ml

1.1

0.9

0.17

269

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

117

1.80

1.74

1.2

1.5

nmol/l

1.4

3.5

0.61

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

132

1.75

1.73

2.4

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

132

1.75

1.73

2.4

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

132

1.75

1.73

2.4

1.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

474

1.38

1.72

1.2

1.1

—

(1616796) Gas panel - Central venous blood

348

1.45

1.71

2.9

2.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.14

1.71

2.7

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.14

1.71

2.7

2.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

163

1.66

1.71

2.3

1.8

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

258

1.52

1.71

2.1

1.7

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.01

1.69

1.1

1.0

—

(3045142) Bone marrow Pathology biopsy report

141

1.71

1.68

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

228

1.54

1.65

1.3

1.2

—

(3003396) Base excess in Arterial blood by calculation

180

1508

1.21

1.64

9.7

8.2

mmol/l

0.3

0.8

1.33

144

1158

(21494434) Karyotype in Bone marrow

105

1.82

1.63

1.2

—

(3003694) ABO and Rh group [Type] in Blood

842

7865

1.10

1.59

1.7

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

3.00

1.58

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.00

1.58

1.5

1.8

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

289

1.46

1.55

3.6

3.3

mg/l

27.9

60.3

0.84

230

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

168

1407

1.21

1.55

2.2

2.1

ml/min/173m2

78.9

78.5

0.04

530

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.11

1.55

1.2

1.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.28

1.53

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

178

1.58

1.48

1.1

u/l

1.0

1.23

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

124

1012

1.24

1.48

1.7

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

124

1.70

1.47

1.2

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

480

1.34

1.46

1.1

—

(44806071)

2.37

1.45

1.1

—

(3011648) Oxygen content in Venous blood

117

1.71

1.45

1.7

2.2

11.1

0.00

117

(3022475) Manganese [Moles/volume] in Blood

3.13

1.44

1.0

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

604

1.30

1.44

2.0

1.8

—

(3027801) Oxygen [Partial pressure] in Arterial blood

178

1513

1.19

1.42

9.7

8.1

kpa

13.0

13.3

0.20

166

1447

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

178

1513

1.19

1.42

9.8

8.1

kpa

5.0

5.1

0.37

165

1445

(3009214) Lutropin [Units/volume] in Serum or Plasma

135

1118

1.22

1.41

1.4

1.3

u/l

8.0

9.3

0.78

107

942

(3004809) Band form neutrophils/100 leukocytes in Blood

229

1.49

1.41

2.2

3.1

1.3

1.5

0.13

188

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

324

2886

1.14

1.41

1.6

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

173

1.57

1.40

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.25

1.40

1.1

1.2

—

(3010421) pH of Blood

415

1.36

1.39

4.3

2.9

7.4

0.09

348

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.00

1.38

1.3

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2046

19992

1.11

1.36

3.4

3.1

mmol/l

1.2

0.22

1899

18985

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

167

1.56

1.34

1.0

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

1.78

1.33

1.4

e6/l

1174.4

2655.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

506

1.31

1.32

1.1

u/ml

2.1

3.9

1.10

200

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

533

0.71

1.31

1.8

1.6

mmol/l

8.0

7.5

0.69

322

(3022621) pH of Urine by Test strip

155

1313

1.19

1.30

2.5

2.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

395

1.35

1.29

1.6

1.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.89

1.28

1.8

2.2

umol/l

17.7

14.7

0.50

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

439

1.33

1.28

4.1

4.0

56.9

56.8

0.02

439

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.94

1.27

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.94

1.27

1.3

1.0

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

388

1.35

1.26

1.9

1.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

154

1.56

1.25

3.1

3.4

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

432

1.33

1.25

3.8

3.7

e9/l

3.6

4.0

0.85

432

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.77

1.23

1.3

1.2

—

(4027681)

212

1.47

1.23

1.4

1.3

—

(3021788) Differential panel - Synovial fluid

279

1.40

1.22

1.7

1.6

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.17

1.21

4.1

2.8

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

454

1.31

1.18

1.1

1.0

u/ml

0.0

0.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

190

1.48

1.16

1.6

1.2

u/ml

0.7

0.4

0.29

(3050129) First trimester maternal screen panel - Serum or Plasma

258

2298

1.14

1.15

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

540

5798

0.91

1.11

4.1

3.4

estimate

0.0

0.27

201

2190

(4281824)

184

1.47

1.10

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

391

3580

1.11

1.10

1.6

pmol/l

17417859.3

42172945.4

0.63

333

3130

(3019150) Specific gravity of Urine by Refractometry

502

4661

1.10

1.07

3.6

3.3

kg/l

1.0

0.16

685

(3013293) Extractable nuclear Ab [Presence] in Serum

2.12

1.05

3.0

1.7

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

178

1.47

1.05

1.3

1.6

promille

2.0

1.3

1.41

141

(3014148) Varicella zoster virus Ab [Titer] in Serum

463

1.28

1.05

1.2

—

(4306422)

410

1.30

1.05

1.1

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

715

1.22

1.04

1.2

1.1

u/ml

1.7

1.5

0.06

294

(3045424) Erythrocytes [Presence] in Urine

341

1.33

1.03

1.5

1.4

—

(4034850)

642

0.77

1.01

7.2

7.9

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

386

1.30

1.01

1.9

1.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

107

0.47

1.01

1.2

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

108

0.46

1.00

1.2

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

719

1.22

1.00

14.3

11.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

471

0.74

0.99

2.8

4.1

mmol/l

1.3

1.4

0.25

462

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

107

1.59

0.99

2.6

3.0

mg/l

8.5

7.0

0.29

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

146

1265

1.16

0.99

1.7

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

675

1.22

0.98

2.3

2.0

—

(3007463) Buprenorphine [Presence] in Urine

2.18

0.98

3.2

4.4

—

(3017704) Immunofixation for Urine

1.86

0.96

1.1

1.7

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.86

0.96

1.4

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.86

0.96

1.4

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.86

0.96

1.4

1.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

141

1222

1.16

0.96

3.8

4.2

ug/l

5.6

47.2

0.81

109

913

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

267

1.35

0.96

1.7

1.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

387

0.72

0.95

3.1

mg/l

16.5

23.3

1.04

237

(3009871) Measles virus Ab [Titer] in Serum

1.65

0.94

1.5

1.7

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

634

1.22

0.93

1.1

u/ml

0.3

1.7

4.74

154

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

226

2031

1.12

0.92

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.15

0.91

3.2

1.5

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.15

0.91

1.2

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

225

2023

1.12

0.91

1.6

—

(3012441) Differential panel - Pleural fluid

1.63

0.91

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

367

1.29

0.90

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

143

1.47

0.89

2.1

2.8

46.0

54.7

0.95

100

(3017509) Phencyclidine [Presence] in Urine

1.91

0.88

1.0

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.65

0.88

1.2

1.7

—

(3014007) Fractional oxyhemoglobin in Arterial blood

832

1.18

0.88

10.9

10.2

94.0

94.3

0.19

827

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.79

0.87

1.9

2.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

103

1.56

0.87

1.1

1.3

u/l

188.0

350.4

0.81

(3035933) Granulocytes/100 leukocytes in Blood

1.58

0.87

1.1

1.6

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

238

1.35

0.86

1.3

—

34.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

153

1.44

0.85

2.1

2.5

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

291

1.31

0.84

1.1

96.9

94.3

0.21

270

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

1.59

0.84

1.0

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.78

0.84

1.1

1.0

ug/l

113.7

72.8

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

179

1.40

0.84

2.0

1.4

g/l

0.9

1.0

0.22

179

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

231

1.35

0.83

1.4

1.7

—

(3036603) Volume of Urine

121

1.49

0.82

1.3

1.6

—

2130.8

—

(4024509)

146

1.44

0.82

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

197

1.37

0.82

1.3

1.5

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.88

0.81

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.88

0.81

1.0

—

(3024263) Appearance of Synovial fluid

1.65

0.81

1.6

2.1

—

(40768806) Pleura Pathology biopsy report

1.58

0.81

1.4

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

454

1.24

0.81

4.0

3.7

u/ml

66.5

2790.3

0.67

390

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

155

1.42

0.81

1.7

1.3

nmol/l

1.6

1.5

0.18

142

(3044941) Cell count panel - Synovial fluid

241

1.33

0.80

1.5

1.4

—

(3033799) Differential panel - Peritoneal fluid

1.82

0.79

2.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.82

0.79

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

421

1.24

0.77

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

180

1619

1.12

0.75

4.9

4.4

1.2

0.9

0.44

393

(3014133) Dog dander IgE Ab [Units/volume] in Serum

560

1.20

0.74

1.1

1.0

u/ml

2.1

3.9

0.98

213

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.84

0.73

1.3

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.84

0.73

1.1

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

167

1.38

0.73

1.7

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

125

1.44

0.72

1.5

1.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

202

1.34

0.72

1.1

1.0

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

654

1.18

0.72

1.5

1.4

pmol/l

68.6

101.0

0.58

638

(3021440) Promyelocytes/100 leukocytes in Blood

172

1548

1.12

0.72

5.0

4.4

0.1

0.2

1.27

367

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.61

0.72

4.9

2.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

187

1692

1.11

0.71

3.2

2.6

—

(40758292) HTLV I+II Ab panel - Serum

1.75

0.71

1.4

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

109

1.47

0.71

1.2

1.7

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.92

0.70

1.2

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

101

1.49

0.70

1.3

1.2

—

(3035285) Chloride [Moles/volume] in Venous blood

143

0.63

0.69

3.0

2.3

mmol/l

107.2

105.9

—

143

(3041354) Potassium [Moles/volume] in Venous blood

143

0.63

0.69

3.0

2.3

mmol/l

3.9

4.0

—

143

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

409

1.23

0.69

2.6

2.7

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.85

0.68

1.2

1.0

—

(3025159) Blasts/100 leukocytes in Blood

165

1488

1.12

0.68

5.0

4.5

0.0

0.3

0.74

312

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

736

1.16

0.65

1.4

1.5

nmol/l

0.5

0.16

607

(3029075) Extractable nuclear Ab panel - Serum

1.57

0.65

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

672

6436

1.06

0.64

3.2

2.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

112

1.43

0.63

1.6

2.0

u/field

0.2

2.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

129

1.40

0.63

1.4

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

216

1.30

0.63

1.6

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.52

0.62

1.2

1.7

—

(40768800) Prostate Pathology biopsy report

147

1.36

0.61

1.1

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

147

1.36

0.61

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

1.67

0.61

1.4

1.7

g/l

9.3

12.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

139

0.65

0.60

3.0

2.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

122

1.40

0.60

1.2

1.4

—

(3000330) Specific gravity of Urine by Test strip

809

1.14

0.59

3.2

2.7

—

(3024932) HLA-DR beta [Type]

1.56

0.58

1.2

1.1

—

(3024471) HLA-A [Type]

1.56

0.58

1.0

—

(3015183) Erythrocyte sedimentation rate

185

0.70

0.58

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

184

1.31

0.57

1.9

1.7

50.8

55.8

0.26

115

(3023419) Bacteria identified in Sputum by Culture

176

1.31

0.56

4.1

2.8

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.51

0.56

1.2

1.4

—

(3001556) Androgen free Index in Serum or Plasma

1.46

0.56

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

185

1.30

0.56

1.1

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

1.42

0.54

1.1

1.6

nmol/l

145.8

138.6

0.14

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

119

1319

0.90

0.54

5.2

3.0

mmol/l

1.2

0.50

105

1138

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.49

0.53

1.2

1.4

—

(3042733) HLA Ab [Presence] in Serum

1.43

0.52

5.2

4.8

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

107

1190

0.89

0.52

1.8

2.0

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

810

0.87

0.51

10.1

7.6

mmol/l

24.7

24.2

0.73

749

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.41

0.51

1.2

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.41

0.51

1.2

1.4

—

(40768441) Liver Pathology biopsy report

135

1.34

0.51

1.2

1.5

—

(3034426) Prothrombin time (PT)

1.42

0.50

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

325

1.20

0.49

4.4

3.1

umol/l

31.1

33.5

0.34

283

(21494890) Protein electrophoresis panel - 24 hour Urine

101

1.39

0.49

2.4

2.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

369

3504

1.06

0.49

1.5

—

(3020491) Glucose [Moles/volume] in Blood

181

1.27

0.48

2.6

1.6

mmol/l

6.3

5.9

0.35

141

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

146

1.30

0.47

1.1

miu/ml

1533.1

1519.8

0.02

146

(3019060) Gas panel - Arterial blood

813

0.88

0.46

9.0

5.5

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

120

0.67

0.45

1.1

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

103

1.36

0.45

1.4

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

174

1.27

0.45

8.5

6.0

mg/l

10.5

10.4

0.02

161

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

838

1.11

0.44

11.2

10.0

1.3

1.4

0.23

832

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

247

1.22

0.44

1.3

1.5

—

(3002179) Metamyelocytes/100 leukocytes in Blood

163

1511

1.08

0.44

5.0

4.1

0.6

0.12

299

(3003181) Sodium [Moles/volume] in Urine

193

1.25

0.43

1.4

1.5

mmol/l

51.8

69.8

1.95

162

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

0.64

0.42

1.0

1.5

pmol/l

12.6

13.4

—

(40761536) Microorganisms panel - Urine sediment

191

2041

0.93

0.42

4.4

3.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

842

1.11

0.41

11.3

10.0

0.7

0.32

837

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

348

0.83

0.41

1.9

1.3

—

(3021901) Oxygen saturation in Capillary blood

222

1.22

0.41

2.3

2.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

342

1.17

0.41

2.6

ug/min

93.3

115.0

0.11

226

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.1

—

(3020393) Adenovirus Ag [Presence] in Stool

0.00

0.40

0.0

1.0

—

(40768795) Lymph node Pathology biopsy report

168

1.25

0.40

1.3

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

816

1.11

0.40

3.0

2.5

e6/l

0.2

0.18

781

(3044007) Cell count panel - Peritoneal fluid

1.43

0.39

2.4

2.2

—

(3010937) Rubella virus Ab [Presence] in Serum

1.39

0.38

1.0

1.1

—

(40761535) Cells panel - Urine sediment

150

1397

1.08

0.38

3.6

3.2

—

(3016502) Oxygen saturation in Arterial blood

142

1320

1.08

0.37

11.5

8.8

95.9

96.3

0.29

136

1269

(3008295) Osmolality of Serum or Plasma

179

1.23

0.37

1.2

1.6

mosm/kgh2o

301.4

283.1

1.57

143

(40768793) Breast Pathology biopsy report

535

1.12

0.36

1.4

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.33

0.35

1.2

1.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

679

1.11

0.35

1.6

2.1

iu/l

2.1

4.6

4.17

286

(3039443) Prostate specific Ag panel - Serum or Plasma

283

1.17

0.34

1.5

1.6

—

(3047189) Immunofixation for 24 hour Urine

1.31

0.33

3.2

1.7

—

(3014271) Vancomycin [Susceptibility]

1.31

0.33

5.0

2.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

210

1.19

0.32

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

295

1.15

0.31

1.4

1.5

—

(3032773) Endomysium IgG Ab [Titer] in Serum

258

1.16

0.31

1.0

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

268

1.16

0.30

3.6

4.2

u/ml

208.9

80.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

157

1.21

0.29

1.1

1.2

—

(40768446) Kidney Pathology biopsy report

1.32

0.28

1.9

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.30

0.28

1.4

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.29

0.28

1.1

—

(4133840)

1.29

0.28

1.5

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.27

0.27

4.1

2.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

119

0.76

0.27

1.4

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

311

0.87

0.27

1.3

1.5

mmol/l

15.2

12.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

215

0.84

0.27

1.6

1.5

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

224

1.16

0.27

1.2

1.0

u/ml

0.9

0.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

132

1247

1.06

0.26

12.1

9.2

g/l

120.9

123.4

0.76

127

1195

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

550

0.91

0.25

1.8

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

179

1.17

0.25

1.1

1.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

179

1.17

0.25

2.5

3.2

—

(3042631) Mycobacterium sp identified in Specimen

142

1.20

0.24

2.8

2.9

—

(40760888) Immunoglobulin light chains.free panel - Serum

227

1.15

0.23

3.9

3.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

337

0.89

0.22

4.1

3.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

144

1.18

0.22

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

144

1.18

0.22

1.3

1.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

210

1.14

0.21

1.2

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3006598) pH of Arterial cord blood

0.00

0.21

0.0

1.1

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

0.21

0.0

1.1

—

7.2

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.1

—

8.4

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

0.21

0.0

1.1

—

4.6

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.21

0.0

1.1

—

41.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.21

0.0

1.1

—

(40762814) Titanium [Mass/volume] in Blood

0.00

0.21

0.0

2.3

—

3.9

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.20

0.0

7.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

114

0.79

0.20

1.4

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.20

0.19

1.5

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

327

1.10

0.19

2.7

2.3

—

(3006462) Nitrate [Presence] in Urine

1.22

0.19

2.6

2.3

—

(3004451) EKG impression Narrative

1.21

0.18

1.1

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

100

1.20

0.18

1.0

1.1

105.5

91.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.17

0.17

2.0

3.4

—

(3017569) Oxygen content in Arterial blood

1.17

0.17

1.1

3.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

562

1.07

0.17

4.0

3.3

47.2

49.6

0.32

557

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

0.76

0.17

1.0

1.1

—

69.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

205

1.12

0.17

1.1

1.3

—

(3012565) Volume of 24 hour Urine

0.78

0.14

4.3

2.6

2135.7

2031.0

—

(3020891) Body temperature

509

1.06

0.14

4.3

4.6

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

103

1.17

0.13

1.9

1.7

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

109

0.83

0.13

1.0

—

(4211845)

104

1.15

0.12

2.5

2.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

158

0.89

0.12

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

476

0.94

0.11

2.0

ug/l

2.0

0.01

427

(3047181) Lactate [Moles/volume] in Blood

465

0.95

0.11

13.3

6.5

mmol/l

1.2

0.01

393

(40760892) CBC W Ordered Manual Differential panel - Blood

562

5556

1.01

0.10

4.4

4.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.11

0.09

2.0

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.11

0.09

3.2

3.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.11

0.09

3.2

3.1

—

(3035880) pH of Pleural fluid

1.06

0.09

1.0

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

832

1.03

0.09

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

0.77

0.08

1.0

1.1

—

79.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.14

0.08

1.1

1.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

1.08

0.08

1.3

1.0

u/ml

0.0

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.04

0.08

2.4

1.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.04

0.08

2.4

1.9

—

(3020874) Milk IgE Ab [Units/volume] in Serum

215

1.07

0.07

1.2

1.0

u/ml

2.9

1.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

118

1.10

0.07

1.3

1.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

1.11

0.06

1.0

1.1

128.7

115.3

0.51

(44790048)

207

1.06

0.06

1.8

1.5

—

(44790049)

207

1.06

0.06

1.8

1.5

—

(44790047)

207

1.06

0.06

1.8

1.5

—

(44806118)

207

1.06

0.06

1.8

1.5

—

(3016750) Collection duration of Urine

1.11

0.05

2.0

2.6

min

473.8

508.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

473

0.97

0.04

1.3

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

853

8561

0.99

0.04

3.6

3.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

289

1.04

0.04

1.2

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

121

1.07

0.03

1.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

185

1.03

0.00

2.2

1.9

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

139

1.01

0.00

2.1

1.3

e6/l

26112.5

81792.6

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

209

1.00

0.00

20.1

13.0

nmol/l

679.8

829.1

1.17

201

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

875

1.01

0.00

1.3

ug/l

2.7

3.9

1.61

822

(3004775) Volume in Urine collected for unspecified duration

108

1.02

0.00

1.8

2.5

657.0

581.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

138

1.01

0.00

6.1

7.0

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

152

0.99

0.00

4.1

2.1

34.6

32.2

0.96

152

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.03

0.00

1.0

1.2

115.0

91.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

4.6

—

386.9

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.5

—

2.6

—

(3001729) Color of Synovial fluid

0.00

0.0

1.3

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.0

4.8

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.6

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.0

—

3.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.0

2.8

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.91

0.00

2.3

3.2

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

2.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

1.02

0.00

1.0

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.91

0.00

4.7

6.4

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.0

4.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.97

0.00

1.3

3.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.97

0.00

3.0

1.5

ug/l

9.8

7.8

—

(3000012) Reticulocyte production index

1.01

0.00

1.3

1.7

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

4.0

—

(3020650) Glucose [Presence] in Urine

0.95

0.00

1.3

1.4

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_ANOGENITAL_HERPES_SIMPLEX and mortality.

Females

Parameter	HR [95% CI]	p-value
AB1_ANOGENITAL_HERPES_SIMPLEX	1.478 [1.24, 1.77]	< 0.001
Birth year	0.999 [0.99, 1.01]	0.774

During the follow-up period (1.1.1998 — 31.12.2019), 245 out of 9937 females with AB1_ANOGENITAL_HERPES_SIMPLEX died.

Males

Parameter	HR [95% CI]	p-value
AB1_ANOGENITAL_HERPES_SIMPLEX	1.04 [0.89, 1.22]	0.631
Birth year	0.987 [0.98, 1.0]	0.023

During the follow-up period (1.1.1998 — 31.12.2019), 264 out of 5301 males with AB1_ANOGENITAL_HERPES_SIMPLEX died.

Mortality risk

Mortality risk for people of age

years, who have AB1_ANOGENITAL_HERPES_SIMPLEX.

N-year risk	Females	Males
1	0.155%	0.245%
5	1.036%	1.155%
10	2.609%	2.958%
15	4.978%	5.608%
20	8.779%	9.633%

Relationships between endpoints

↥

Index endpoint: AB1_ANOGENITAL_HERPES_SIMPLEX – Anogenital herpesviral [herpes simplex] infection

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Anogenital herpesviral [herpes simplex] infection

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints